BioPharmos Group is awarded with Grand Prix Européen de la Qualité (Geneva, Switzerland) in 2012 in the "Leader in the application of innovation in biotechnology" nomination.
"Synthetic peptides with a non-narcotic type of analgesic effect”. The number of short peptides with a non-narcotic type of analgesic effect are developed and protected by a patent.
Patent RF №2508295
"Synthetic peptides with a non-narcotic type of analgesic effect”, as a result of the consideration of the Federal Institute of Industrial Property experts, is included in the list of "100 best inventions of 2015" (p. 44, p.№ 60).
Gazelle of Business 2012
BIOPHARMOS Co. Ltd. receives 2 awards - the company is in the TOP30 of rapidly growing companies, and receives the "Best Product" award.
Expert of the Year 2011
Prevention and treatment of pregnancy miscarriage
Scientific achievements, Russian Academy of Sciences
Vitagmal® is included among the scientific achievements of the Russian Academy of Sciences in 2007.
Prevention of influenza, the common cold and acute respiratory viral infection
Vitagmal® is included into the list of the most effective means for the prevention of influenza, the common cold and acute respiratory viral infection, recommended by the Order of the St. Petersburg Administration No 3973/48 from 21.11.2001.
Anti-teratogen agent. The property of Polyscias filicifolia biomass extract to reduce the risk of inborn anomalies in children is protected by patent.